Middle East And Africa Cell Culture Media Market Trends

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Middle East and Africa Cell Culture Media Market Size, Share, and Trends Analysis Report Trends

  • Healthcare
  • Published Report
  • Oct 2024
  • MEA
  • 350 Pages
  • No of Tables: 86
  • No of Figures: 33

“Increase in R&D Spending on Biopharmaceutical Projects”

The increase in R&D spending on biopharmaceutical projects is driving the growth of the global cell culture media market. Biopharmaceutical companies are investing heavily in R&D to develop new treatments and therapies, which requires the use of high-quality cell culture media to support the growth and testing of biological products. As a result, the demand for cell culture media is increasing as biopharmaceutical companies require advanced cell culture media to support their R&D activities. For Instance, In July 2024, according to an article published in The Economic Times, the revised estimate of allocation to the Ministry of Health and Family Welfare showed an increase of approx. 1.73% over the revised estimate of 2022-23. This is done in the aim of developing high-value novel drugs, bio-pharmaceuticals and biosimilar that require considerable research and development efforts. The development of new biological products, such as monoclonal antibodies, vaccines, and gene therapies, requires the use of advanced cell culture media. These products require specific growth conditions, such as temperature, pH, and nutrient levels, which can be challenging to replicate in vitro. Advanced cell culture media that can support the growth and testing of these biological products is driving demand for specialized cell culture media.

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

5 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE

6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE

6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS

6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT

6.2 RESTRAINTS

6.2.1 RISKS ASSOCIATED WITH CONTAMINATION

6.2.2 HIGH COST OF PRODUCTION

6.3 OPPORTUNITIES

6.3.1 RISING COLLABORATION AND PARTNERSHIPS

6.3.2 INCREASED DEMAND FOR BIOPHARMACEUTICALS AND VACCINES

6.3.3 INNOVATIONS IN 3D CELL CULTURE

6.4 CHALLENGES

6.4.1 COMPLEXITY OF MEDIA FORMULATION

6.4.2 INTENSE MARKET COMPETITION

7 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE

7.1 OVERVIEW

7.2 CHEMICALLY DEFINED MEDIA

7.3 CLASSICAL MEDIA

7.4 SERUM-FREE MEDIA

7.4.1 CHO MEDIA

7.4.2 HEK 293 MEDIA

7.4.3 CAR T-CELL MEDIA

7.4.4 VERO CELL MEDIA

7.4.5 BHK MEDIA

7.4.6 INSECT CELL MEDIA

7.4.7 SERUM-FREE CELL MEDIA

7.4.8 OTHER SERUM-FREE MEDIA

7.5 SPECIALTY MEDIA

7.6 STEM CELL MEDIA

7.6.1 MESENCHYMAL STEM CELLS (MSCS)

7.6.2 NEURAL STEM CELLS (NSCS)

7.6.3 EMBRYONIC STEM CELLS (ESCS)

7.6.4 BONE MARROW

7.6.5 OTHERS

7.7 LYSOGENY BROTH (LB)

7.8 CUSTOM MEDIA FORMULATION

7.9 OTHERS

8 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 BIOPHARMACEUTICAL PRODUCTION

8.2.1 MONOCLONAL ANTIBODIES

8.2.2 VACCINES PRODUCTION

8.2.3 OTHERS

8.3 DRUG SCREENING & DEVELOPMENT

8.4 DIAGNOSTICS

8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING

8.5.1 STEM CELL AND GENE THERAPY

8.5.2 OTHERS

8.6 OTHERS

9 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY END USER

9.1 OVERVIEW

9.2 BIOPHARMACEUTICAL COMPANIES

9.3 BIOTECHNOLOGY ORGANIZATIONS

9.4 ACADEMIC AND RESEARCH LABORATORIES

9.5 HOSPITALS

9.6 DIAGNOSTIC CENTERS

9.7 CELL BANKS

9.8 FORENSIC LABORATORIES

9.9 OTHERS

10 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDERS

10.3 THIRD PARTY DISTRIBUTION

10.4 RETAILS SALES

11 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY REGION

11.1 MIDDLE EAST AND AFRICA

11.1.1 SOUTH AFRICA

11.1.2 SAUDI ARABIA

11.1.3 U.A.E

11.1.4 EGYPT

11.1.5 ISRAEL

11.1.6 REST OF MIDDLE EAST AND AFRICA

12 MIDDLE EAST AND AFRICA MULTIPLE HEREDITARY EXOSTOSIS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

13 SWOT ANALYSIS

14 COMPANY PROFILES

14.1 THERMO FISHER SCIENTIFIC INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 MERCK KGAA

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 DANAHER CORPORATION (CYTIVA)

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 SARTORIUS AG

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 LONZA

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENT

14.6 CORNING INCORPORATED

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 COMPANY SHARE ANALYSIS

14.6.4 PRODUCT PORTFOLIO

14.6.5 RECENT UPDATES

14.7 AJINOMOTO CO., INC

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 AKRON BIOTECH

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 BD

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT UPDATES

14.1 BIO-RAD LABORATORIES, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 REVENUE ANALYSIS

14.10.3 PRODUCT PORTFOLIO

14.10.4 RECENT DEVELOPMENT

14.11 CAISSON LABS INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT UPDATES

14.12 CELL APPLICATION, INC.

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT UPDATES

14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 FUJIFILM HOLDINGS CORPORATION

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT UPDATES

14.15 HIMEDIA LABORATORIES

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT UPDATES

14.16 KOH JIN-BIO CO., LTD.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT UPDATES

14.17 PAN-BIOTECH

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT UPDATES

14.18 PROMOCELL GMBH

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT UPDATES

14.19 SERA-SCANDIA A/S

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 STEMCELL TECHNOLOGIES

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 TAKARA BIO INC.

14.21.1 COMPANY SNAPSHOT

14.21.2 REVENUE ANALYSIS

14.21.3 PRODUCT PORTFOLIO

14.21.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

List of Table

TABLE 1 GMP REQUIREMENTS

TABLE 2 SCOPE OF THE CURRENT DOCUMENT

TABLE 3 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (VOLUME)

TABLE 5 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 6 MIDDLE EAST AND AFRICA CHEMICALLY DEFINED MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA CLASSICAL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA SPECIALTY MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA LYSOGENY BROTH (LB) IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA CUSTOM MEDIA FORMULATION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL PRODUCTION  IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA DRUG SCREENING & DEVELOPMENT IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA DIAGNOSTICS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL COMPANIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA BIOTECHNOLOGY ORGANIZATIONS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA ACADEMIC AND RESEARCH LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA HOSPITALS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA DIAGNOSTIC CENTERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA CELL BANKS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA FORENSIC LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA DIRECT TENDERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA RETAIL SALES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 46 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 47 SOUTH AFRICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 48 SOUTH AFRICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 49 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 50 SOUTH AFRICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 51 SOUTH AFRICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 52 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 53 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 54 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 55 SAUDI ARABIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 56 SAUDI ARABIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 57 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 58 SAUDI ARABIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 59 SAUDI ARABIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 60 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 61 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 62 U.A.E CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 63 U.A.E SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 64 U.A.E STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 65 U.A.E CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 66 U.A.E BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 67 U.A.E REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 68 U.A.E CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 69 U.A.E CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 70 EGYPT CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 71 EGYPT SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 72 EGYPT STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 73 EGYPT CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 74 EGYPT BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 75 EGYPT REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 76 EGYPT CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 77 EGYPT CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 78 ISRAEL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 79 ISRAEL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 80 ISRAEL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 81 ISRAEL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 82 ISRAEL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 83 ISRAEL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 84 ISRAEL CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 85 ISRAEL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 86 REST OF MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

List of Figure

FIGURE 1 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: SEGMENTATION

FIGURE 11 EXECUTIVE SUMMARY

FIGURE 12 STRATEGIC DECISIONS

FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE IS DRIVING THE GROWTH OF THE MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET FROM 2024 TO 2031

FIGURE 14 THE CHEMICALLY DEFINED MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET IN 2024 AND 2031

FIGURE 15 DROC ANALYSIS

FIGURE 16 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY TYPE, 2023

FIGURE 17 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY TYPE, 2024-2031 (USD MILLION)

FIGURE 18 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY TYPE, CAGR (2024-2031)

FIGURE 19 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY TYPE, LIFELINE CURVE

FIGURE 20 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY APPLICATION, 2023

FIGURE 21 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY APPLICATION, 2024-2031 (USD MILLION)

FIGURE 22 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 23 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 24 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY END USER, 2023

FIGURE 25 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 26 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY END USER, CAGR (2024-2031)

FIGURE 27 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY END USER, LIFELINE CURVE

FIGURE 28 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 29 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 30 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 31 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 32 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: SNAPSHOT

FIGURE 33 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)

Frequently Asked Questions

The market is segmented based on Middle East and Africa Cell Culture Media Market Segmentation, By Type (Chemically Defined Media, Classical Media, Serum-Free Media, Specialty Media, Stem Cell Media, Lysogeny Broth (LB), Custom Media Formulation, and Others), Application (Biopharmaceutical Production, Drug Screening & Development, Diagnostics, Regenerative Medicine & Tissue Engineering, and Others), End-User (Biopharmaceutical Companies, Biotechnology Organizations, Academic and Research Laboratories, Hospitals, Diagnostic Centers, Cell Banks, Forensic Laboratories, and Others), Distribution Channel (Direct Tenders, Third Party Distribution, and Retails Sales) – Industry Trends and Forecast to 2031 .
The Middle East And Africa Cell Culture Media Market size was valued at USD 212.62 USD Million in 2023.
The Middle East And Africa Cell Culture Media Market is projected to grow at a CAGR of 12.2% during the forecast period of 2024 to 2031.
The market report covers data from the South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.